Institutional investors purchased a net $936.0 thousand shares of KERX during the quarter ended December 2016, and now own 64.68% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DEERFIELD MANAGEMENT COMPANY LP Bought 1.3 Million shares of Keryx Biopharmaceuticals ...